|0.061||-0.0035 / -5.43%|
As of 2:21pm ET
|0.061||0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Provectus Biopharmaceuticals Inc have a median target of 3.50, with a high estimate of 3.50 and a low estimate of 3.50. The median estimate represents a +5,637.70% increase from the last price of 0.06.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.